These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23688317)

  • 1. Pharmacological primary and secondary cardiovascular prevention among diabetic patients in a multiethnic general practice population: still room for improvements.
    Tran AT; Straand J; Dalen I; Birkeland KI; Claudi T; Cooper JG; Meyer HE; Jenum AK
    BMC Health Serv Res; 2013 May; 13():182. PubMed ID: 23688317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of care for patients with type 2 diabetes in general practice according to patients' ethnic background: a cross-sectional study from Oslo, Norway.
    Tran AT; Diep LM; Cooper JG; Claudi T; Straand J; Birkeland K; Ingskog W; Jenum AK
    BMC Health Serv Res; 2010 May; 10():145. PubMed ID: 20507647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register.
    Karlsson SA; Franzén S; Svensson AM; Miftaraj M; Eliasson B; Andersson Sundell K
    BMC Health Serv Res; 2018 Nov; 18(1):900. PubMed ID: 30486824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
    Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
    Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint and distinct risk factors associated with micro- and macrovascular complications in a cohort of type 2 diabetic patients cared through disease management.
    Ciardullo AV; Daghio MM; Bevini M; Feltri G; Novi D; Fattori G; Borsari S; Donato CD
    Acta Diabetol; 2010 Dec; 47(4):301-8. PubMed ID: 20383650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnic and gender differences in the management of type 2 diabetes: a cross-sectional study from Norwegian general practice.
    Tran AT; Berg TJ; Gjelsvik B; Mdala I; Thue G; Cooper JG; Nøkleby K; Claudi T; Bakke Å; Sandberg S; Jenum AK
    BMC Health Serv Res; 2019 Nov; 19(1):904. PubMed ID: 31779621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are general practitioners characteristics associated with the quality of type 2 diabetes care in general practice? Results from the Norwegian ROSA4 study from 2014.
    Tran AT; Bakke Å; Berg TJ; Gjelsvik B; Mdala I; Nøkleby K; Shakil Rai A; Cooper JG; Claudi T; Løvaas K; Thue G; Sandberg S; Jenum AK
    Scand J Prim Health Care; 2018 Jun; 36(2):170-179. PubMed ID: 29717939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
    Boytsov S; Logunova N; Khomitskaya Y;
    Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease by diabetes status in five ethnic minority groups compared to ethnic Norwegians.
    Tran AT; Straand J; Diep LM; Meyer HE; Birkeland KI; Jenum AK
    BMC Public Health; 2011 Jul; 11():554. PubMed ID: 21752237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel determinants preventing achievement of major cardiovascular targets in type 2 diabetes.
    Camara S; Bouenizabila E; Hermans MP; Ahn SA; Rousseau MF
    Diabetes Metab Syndr; 2014; 8(3):145-51. PubMed ID: 25220917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological management of modifiable cardiovascular risk factors (blood pressure and lipids) following diagnosis of myocardial infarction, stroke and diabetes: comparison between population-based studies in Russia and Norway.
    Cook S; Hopstock LA; Eggen AE; Bates K; Iakunchykova O; Kontsevaya A; McKee M; Schirmer H; Voevoda M; Kudryavtsev AV; Malyutina S; Leon DA
    BMC Cardiovasc Disord; 2020 May; 20(1):234. PubMed ID: 32430002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exenatide once weekly improved glycaemic control, cardiometabolic risk factors and a composite index of an HbA1c < 7%, without weight gain or hypoglycaemia, over 52 weeks.
    Bergenstal RM; Li Y; Porter TK; Weaver C; Han J
    Diabetes Obes Metab; 2013 Mar; 15(3):264-71. PubMed ID: 23078638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes.
    Gouni-Berthold I; Berthold HK; Mantzoros CS; Böhm M; Krone W
    Diabetes Care; 2008 Jul; 31(7):1389-91. PubMed ID: 18375411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study.
    Banegas JR; López-García E; Dallongeville J; Guallar E; Halcox JP; Borghi C; Massó-González EL; Jiménez FJ; Perk J; Steg PG; De Backer G; Rodríguez-Artalejo F
    Eur Heart J; 2011 Sep; 32(17):2143-52. PubMed ID: 21471134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in the achievement of HbA
    Bakke Å; Dalen I; Thue G; Cooper J; Skeie S; Berg TJ; Jenum AK; Claudi T; Fjeld Løvaas K; Sandberg S
    Diabet Med; 2020 Sep; 37(9):1471-1481. PubMed ID: 31651045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can traditional risk factors explain the higher risk of cardiovascular disease in South Asians compared to Europeans in Norway and New Zealand? Two cohort studies.
    Rabanal KS; Meyer HE; Tell GS; Igland J; Pylypchuk R; Mehta S; Kumar B; Jenum AK; Selmer RM; Jackson R
    BMJ Open; 2017 Dec; 7(12):e016819. PubMed ID: 29217719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalised treatment targets in type 2 diabetes patients: The Dutch approach.
    Boels AM; Hart HE; Rutten GE; Vos RC
    Prim Care Diabetes; 2017 Feb; 11(1):71-77. PubMed ID: 27633894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seasonal Variations in the Achievement of Guideline Targets for HbA
    Sakamoto M; Matsutani D; Minato S; Tsujimoto Y; Kayama Y; Takeda N; Ichikawa S; Horiuchi R; Utsunomiya K; Nishikawa M
    Diabetes Care; 2019 May; 42(5):816-823. PubMed ID: 30739885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing diabetes care regarding cardiovascular targets at general practice level: Direct@GP.
    Wens J; Gerard R; Vandenberghe H
    Prim Care Diabetes; 2011 Apr; 5(1):19-24. PubMed ID: 21030327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey.
    Charpentier G; Genès N; Vaur L; Amar J; Clerson P; Cambou JP; Guéret P;
    Diabetes Metab; 2003 Apr; 29(2 Pt 1):152-8. PubMed ID: 12746636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.